Distinct stem cell myeloproliferative/T lymphoma syndromes induced by ZNF198-FGFR1 and BCR-FGFR1 fusion genes from 8p11 translocations

Cancer Cell

Volumn 5, Issue 3, 2004, Pages 287-298

  Roumiantsev, Sergei ^a   Krause, Daniela S ^b   Neumann, Carola A ^c   Dimitri, Christopher A ^d   Asiedu, Frances ^b   Cross, Nicholas C P ^e,f   Van Etten, Richard A ^g  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b CENTER FOR BLOOD RESEARCH   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e SALISBURY DISTRICT HOSPITAL   (United Kingdom)

^f UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^g TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; FIBROBLAST GROWTH FACTOR RECEPTOR 1; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; PHOSPHOLIPASE C; PHOSPHOLIPASE C GAMMA1; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; CHROMOSOME TRANSLOCATION; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; ENZYME SUBUNIT; FEMALE; GENE FUSION; GENE MUTATION; HUMAN; HUMAN CELL; MALE; MOUSE; MYELOPROLIFERATIVE DISORDER; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RECEPTOR BINDING; STEM CELL; STEM CELL LEUKEMIA LYMPHOMA SYNDROME; T CELL LYMPHOMA;

ANIMALIA;

EID: 1642421743     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1535-6108(04)00053-4     Document Type: Article

References (38)

1. Cools J., Stover E.H., Boulton C.L., Gotlib J., Legare R.D., Amaral S.M., Curley D.P., Duclos N., Rowan R., Kutok J.L.et al. PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRα-induced myeloproliferative disease. Cancer Cell. 3:2003;459-469.
2. bcr/abl gene of the Philadelphia chromosome. Science. 247:1990;824-830.
3. Demiroglu A., Steer E.J., Heath C., Taylor K., Bentley M., Allen S.L., Koduru P., Brody J.P., Hawson G., Rodwell R.et al. The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1. Transforming activity and specific inhibition of FGFR1 fusion proteins Blood. 98:2001;3778-3783.
4. Druker B., Okuda K., Matulonis U., Salgia R., Roberts T., Griffin J.D. Tyrosine phosphorylation of rasGAP and associated proteins in chronic myelogenous leukemia cell lines. Blood. 79:1992;2215-2220.
5. Fioretos T., Panagopoulos I., Lassen C., Swedin A., Billstrom R., Isaksson M., Strombeck B., Olofsson T., Mitelman F., Johansson B. Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder. The first fusion gene involving BCR but not ABL Genes Chrom. Cancer. 32:2001;302-310.
6. Gu H., Saito K., Klaman L.D., Shen J., Fleming T., Wang Y., Pratt J.C., Lin G., Lim B., Kinet J.P., Neel B.G. Essential role for Gab2 in the allergic response. Nature. 412:2001;186-190.
7. Guasch G., Mack G.J., Popovici C., Dastugue N., Birnbaum D., Rattner J.B., Pebusque M.-J. FGFR1 is fused to the centrosome-associated protein CEP110 in the 8p12 stem cell myeloproliferative disorder with t(8;9)(p12;q33). Blood. 95:2000;1788-1796.
8. Guasch G., Ollendorff V., Borg J.-P., Birnbaum D., Pebusque M.-J. 8p12 stem cell myeloproliferative disorder. the FOP-fibroblast growth factor receptor 1 fusion protein of the t(6;8) translocation induces cell survival mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt/mTOR pathways Mol. Cell. Biol. 21:2001;8129-8142.
9. Guasch G., Popovici C., Mugneret F., Chaffanet M., Pontarotti P., Birnbaum D., Pebusque M.-J. Endogenous retroviral sequence is fused to FGFR1 kinase in the 8p12 stem-cell myeloproliferative disorder with t(8;19)(p12;q13.3). Blood. 101:2003;286-288.
10. Guasch G., Delaval B., Arnoulet C., Xie M.J., Xerri L., Sainty D., Birnbaum D., Pebusque M.J. FOP-FGFR1 tyrosine kinase, the product of a t(6;8) translocation, induces a fatal myeloproliferative disease in mice. Blood. 103:2004;309-312.
11. Inhorn R.C., Aster J.C., Roach S.A., Slapak C.A., Soiffer R., Tantravahi R., Stone R.M. A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/malignancy associated with t(8;13)(p11;q11). description of a distinctive clinicopathological entity Blood. 85:1995;1881-1887.
12. Kantarjian H., Sawyers C.L., Hochhaus A., Guilhot F., Schiffer C., Gambacorti-Passerini C., Niederwieser D., Resta D., Capdeville R., Zoellner U. et al. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. N. Engl. J. Med. 346:2002;645-652.
13. Kuefer M.U., Look A.T., Pulford K., Behm F.G., Pattengale P.K., Mason D.Y., Morris S.W. Retrovirus-mediated gene transfer of NPM-ALK causes lymphoid malignancy in mice. Blood. 90:1997;2901-2910.
14. Larsson H., Klint P., Landgren E., Claesson-Welsh L. Fibroblast growth factor receptor-1-mediated endothelial cell proliferation is dependent on the Src homology (SH) 2/SH3 domain-containing adaptor protein Crk. J. Biol. Chem. 274:1999;25726-25734.
15. Li S., Ilaria R.L., Million R.P., Daley G.Q., Van Etten R.A. The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity. J. Exp. Med. 189:1999;1399-1412.
16. Li S., Couvillon A.D., Brasher B.B., Van Etten R.A. Tyrosine phosphorylation of Grb2 by Bcr/Abl and epidermal growth factor receptor. a novel regulatory mechanism for tyrosine kinase signaling EMBO J. 20:2001;6793-6804. a.
17. Li S., Gillessen S., Tomasson M.H., Dranoff G., Gilliland D.G., Van Etten R.A. Interleukin-3 and granulocyte-macrophage colony-stimulating factor are not required for induction of chronic myeloid leukemia-like myeloproliferative disease in mice by BCR/ABL. Blood. 97:2001;1442-1450. b.
18. Lin H.-Y., Xu J., Ischenko I., Ornitz D.M., Halegoua S., Hayman M.J. Identification of the cytoplasmic regions of fibroblast growth factor (FGF) receptor 1 which play important roles in induction of neurite outgrowth in PC12 cells by FGF-1. Mol. Cell. Biol. 18:1998;3762-3770.
19. Macdonald D., Aguiar R.C., Mason P.J., Goldman J.M., Cross N.C. A new myeloproliferative disorder associated with chromosomal translocations involving 8p11. A review Leukemia. 9:1995;1628-1630.
20. Macdonald D., Reiter A., Cross N.C.P. The 8p11 myeloproliferative syndrome. A distinct clinical entity caused by constitutive activation of FGFR1 Acta Haematol. 107:2002;101-107.
21. Million R.P., Van Etten R.A. The Grb2 binding site is required for induction of chronic myeloid leukemia-like disease in mice by the Bcr/Abl tyrosine kinase. Blood. 96:2000;664-670.
22. Million R.P., Aster J., Gilliland D.G., Van Etten R.A. The Tel-Abl (ETV6-Abl) tyrosine kinase, product of complex (9;12) translocations in human leukemia, induces distinct myeloproliferative disease in mice. Blood. 99:2002;4568-4577.
23. Mohammadi M., Dionne C.A., Li W., Li N., Spivak T., Honegger A.M., Jaye M., Schlessinger J. Point mutation in FGF receptor eliminates phosphatidylinositol hydrolysis without affecting mitogenesis. Nature. 358:1992;681-684.
24. Mohammadi M., Dikic I., Sorokin A., Burgess W.H., Jaye M., Schlessinger J. Identification of six novel autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their importance in receptor activation and signal transduction. Mol. Cell. Biol. 16:1996;977-989.
25. Ollendorff V., Guasch G., Isnardon D., Galindo R., Birnbaum D., Pebusque M.-J. Characterization of FIM-FGFR1, the fusion product of the myeloproliferative disorder-associated t(8;13) translocation. J. Biol. Chem. 274:1999;26922-26930.
26. Ong S.H., Guy G.R., Hadari Y.R., Laks S., Gotoh N., Schlessinger J., Lax I. FRS2 proteins recruit intracellular signaling pathways by binding to diverse targets on fibroblast growth factor and nerve growth factor receptors. Mol. Cell. Biol. 20:2000;979-989.
27. Pear W.S., Aster J.C., Scott M.L., Hasserjian R.P., Soffer B., Sklar J., Baltimore D. Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated notch alleles. J. Exp. Med. 183:1996;2283-2291.
28. Popovici C., Adelaide J., Ollendorff V., Chaffanet M., Guasch G., Jacrot M., Leroux D., Birnbaum D., Pebusque M.-J. Fibroblast growth factor receptor 1 is fused to FIM in stem-cell myeloproliferative disorder with t(8;13)(p12;q12). Proc. Natl. Acad. Sci. USA. 95:1998;5712-5717.
29. Popovici C., Zhang B., Gregoire M.J., Jonveaux P., Lafage-Pochitaloff M., Birnbaum D., Pebusque M.-J. The t(6;8)(q27;p11) translocation in a stem cell myeloproliferative disorder fuses a novel gene, FOP, to fibroblast growth factor receptor 1. Blood. 93:1999;1381-1389.
30. Reiter A., Sohal J., Kulkarni S., Chase A., Macdonald D.H.C., Aguiar R.C.T., Goncalves C., Hernandez J.M., Jennings B.A., Goldman J.M., Cross N.C.P. Consistent fusion of ZNF198 to the fibroblast growth factor receptor-1 in the t(8;13)(p11;q12) myeloproliferative syndrome. Blood. 92:1998;1735-1742.
31. Ren R., Zheng S.Y., Baltimore D. Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites. Genes Dev. 8:1994;783-795.
32. Sattler M., Mohi M.G., Pride Y.B., Quinnan L.R., Malouf N.A., Podar K., Gesbert F., Iwasaki H., Li S., Van Etten R.A.et al. Essential role for Gab2 in transformation by BCR/ABL. Cancer Cell. 1:2002;479-492.
33. Schwaller J., Frantsve J., Aster J., Williams I.R., Tomasson M.H., Ross T.S., Van Rompey L., Peeters P., Van Etten R.A., Ilaria R. Jr. et al. Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myeloid- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion gene. EMBO J. 17:1998;5321-5333.
34. Shah N.P., Nicoll J.M., Nagar B., Gorre M.E., Paquette R.L., Kuriyan J., Sawyers C.L. Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia. Cancer Cell. 2:2002;117-125.
35. Smedley D., Hamoudi R., Clark J., Warren W., Abdul-Rauf M., Somers G., Venter D., Fagan K., Cooper C., Shipley J. The t(8;13)(p11;q11-12) rearrangement associated with an atypical myeloproliferative disorder fuses the fibroblast growth factor receptor 1 gene to a novel gene RAMP. Hum. Mol. Genet. 7:1998;637-642.
36. Smedley D., Demiroglu A., Abdul-Rauf M., Heath C., Cooper C., Shipley J., Cross N.C.P. ZNF198-FGFR1 transforms Ba/F3 cells to growth factor independence and results in high level tyrosine phosphorylation of STATs 1 and 5. Neoplasia. 1:1999;349-355.
37. Xiao S., Nalabolu S.R., Aster J.C., Ma J., Abruzzo L., Jaffe E.S., Stone R., Weissman S.M., Hudson T.J., Fletcher J.A. FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome. Nat. Genet. 18:1998;84-87.
38. Xiao S., McCarthy J.G., Fletcher J.A. ZNF198-FGFR1 transforming activity depends on a novel proline-rich ZNF198 oligomerization domain. Blood. 96:2000;699-704.